Dr (Brig) AK Dhar stands as a beacon in Medical Oncology with an illustrious career that spans from serving the Armed Forces Medical Corps to heading departments in renowned hospitals. His proficiency encompasses a wide range of treatments, from chemotherapy for solid tumors to pioneering the first Bone Marrow Transplant in a Multiple Myeloma patient in India. An alumnus of King George’s Medical College, Lucknow, and a post-doctoral fellow from Tata Memorial Hospital, Mumbai, Dr. Dhar’s contributions to the field are immense. Beyond his academic and clinical pursuits, he has been honored with awards like the Vishisht Seva medal and has been instrumental in establishing various cancer centers and BMT units.

• MBBS – King George’s Medical College, Lucknow
• MD (Internal Medicine) – King George’s Medical College, Lucknow
• Post-Doctoral Fellowship in Medical Oncology – Tata Memorial Hospital, Mumbai

Experience:

• Sr Consultant – Medical Oncology, American Oncology Institute at Aarvy Hospital, Gurugram Service in Armed Forces Medical Corps
• Consultant – Medical Oncology, various Armed Forces Cancer Centres
• Associate Professor of Medicine, Armed Forces Medical College, Pune
• Professor and Department Head of Medical Oncology, Army Hospital, Delhi Cantt

Procedures & Treatment :

• Bone Marrow Transplants including Autologous
• Allogenic
• Unrelated transplants for both children and adults

Personal Achievements :

• Vishisht Seva medal by the President of India (2011)
• Army Commander’s commendation medals on three occasions
• Best Medical Oncologist in Delhi NCR (2014)
• Recognized for establishing DNB Medical Oncology at Army Hospital (R&R) and numerous Bone Marrow Transplant units
• Certificate of Recognition for Contribution under Ayushman Bharat Pradhan Mantri Jan Arogya Yojna (2022)

Publications :

• Dr. Dhar has published multiple papers and delivered presentations in national and international scientific forums.

Specialization :

• Bone Marrow Transplant
• Chemotherapy for Solid Tumors and Hemato-Oncology
• Immunotherapy and Targeted Therapy
• Age-related Cancer Treatment